NT 10-K - Aspira Women's Health Inc. (0000926617) (Filer) Filing
Sentiment: neutral
From the Filing
EDGAR Filing Documents for 0000926617-26-000016 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: SEC Accession No. 0000926617-26-000016 Filing Date 2026-04-01 Accepted 2026-04-01 07:19:07 Documents 1 Period of Report 2025-12-31 Effectiveness Date 2026-04-01 Document Format Files Seq Description Document Type Size 1 NT 10-K awhl-20251231xnt10k.htm NT 10-K 29093 Complete submission text file 0000926617-26-000016.txt 30519 Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400 Aspira Women's Health Inc. (Filer) CIK : 0000926617 (see all company filings) EIN. : 330595156 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2835 In Vitro & In Vivo Diagnostic Substances (CF Office: 03 Life Sciences)